Your doctor hands you a prescription on the way out of the hospital after a heart attack.
Beta blockers. Take them every day. It’s just what you do.
That’s been the standard for four decades. Tens of millions of people worldwide follow this protocol right now. And a landmark international clinical trial just published in the New England Journal of Medicine found that for a huge chunk of those patients, the drug does absolutely nothing.
Nothing.
And for women? The results were worse than nothing.
Let that sink in for a second.
What the REBOOT Trial Actually Found
The study is called the REBOOT Trial. It was led by researchers at Mount Sinai and Spain’s National Center for Cardiovascular Research (CNIC) — not exactly some fringe operation. This was a rigorous, large-scale, international study with no pharmaceutical funding. Let that last part register too.
Researchers enrolled 8,505 heart attack patients across 109 hospitals in Spain and Italy. After leaving the hospital, half were randomly assigned to take beta blockers. The other half didn’t. Everyone received modern standard cardiac care on top of that.
They followed these patients for nearly four years.
The result: beta blockers did not significantly reduce death, repeat heart attack, or hospitalization for heart failure in patients whose hearts were still pumping normally after an uncomplicated heart attack.
That’s the population we’re talking about here — people whose hearts came through the attack with preserved function. No major structural damage. Heart working as it should.
For those patients, the drug did nothing.
Why Were We Prescribing This in the First Place?
Here’s where the story gets interesting, and honestly, a little infuriating.
Beta blockers became standard post-heart attack treatment in an era when cardiac care looked very different. Back then, doctors didn’t have the tools to quickly reopen blocked arteries. They didn’t have modern statins or antiplatelet drugs. The bar for “good recovery” was much lower.
So they prescribed beta blockers to reduce strain on the heart, slow arrhythmias, and cut oxygen demand. And in that context, it made sense.
But medicine evolved. Blocked arteries now get reopened fast, often within hours of a heart attack. Modern drug therapies are far more effective. The landscape changed completely.
The problem? Nobody rigorously tested whether the old standard still applied.
As one of the lead investigators put it, we constantly test new drugs — but it’s much less common to question whether older treatments still make sense in a modern context.
That’s exactly what REBOOT did. And the answer was: for many patients, beta blockers no longer make sense.
The Finding That Should Stop Everyone Cold
The main REBOOT results were significant enough on their own. But a companion study published in the European Heart Journal uncovered something that deserves its own headline.
Women who took beta blockers had a higher risk of death, heart attack, or hospitalization for heart failure compared to women who didn’t take them.
That finding was not seen in men.
Among women with fully normal heart function after their heart attack — defined as a left ventricular ejection fraction of 50% or higher — those treated with beta blockers had a 2.7% higher absolute risk of dying over the following 3.7 years compared to those who weren’t treated.
A drug prescribed to prevent death was associated with more of it. In a specific population.
Doctors will rightly point out that this doesn’t mean patients should stop their prescriptions on their own — and that’s genuinely true. Stopping beta blockers abruptly without medical guidance can cause rebound effects, and the drug still has real benefits for patients with reduced heart function.
But the prescribing pattern needs to change. Full stop.
80% of Patients Are Getting This Drug Right Now
Here’s what makes this data hit differently.
The researchers noted that more than 80% of patients with uncomplicated heart attacks are currently discharged from the hospital on beta blockers. Most of them have preserved heart function. Most of them, if the REBOOT findings hold up, are taking a drug that isn’t helping them.
And it’s not a harmless drug. Known side effects include fatigue, sexual dysfunction, cold extremities, slow heart rate, and sleep problems. For men over 40 who are already dealing with the natural drop in testosterone, energy, and libido that comes with age, those side effects aren’t trivial.
Trading real side effects for zero benefit is a bad deal.
What This Means If You’re a Man Over 40
I’ve got a Human Biology degree, and I spend a lot of time reading up on health and science, but I’m not a doctor and nothing here is medical advice.
That said, here’s what any reasonable person should take from this research:
Know your ejection fraction. If you’ve had a heart attack and your heart function is preserved — meaning your ejection fraction is 50% or higher — you now have legitimate scientific grounds to have a real conversation with your cardiologist about whether you need beta blockers long-term. The REBOOT Trial and a companion study called REDUCE-AMI both point in the same direction.
Talk to your doctor before changing anything. Stopping beta blockers cold is dangerous. Rebound heart rate spikes are real. This conversation needs to happen in a clinical setting, not because you read a blog post.
Push for personalized care. The era of one-size-fits-all cardiac prescribing needs to be over. REBOOT’s own investigators said the same thing. Your cardiologist should be able to explain why you specifically are on beta blockers and what evidence supports that for your situation.
Don’t ignore the side effects. If you’re on beta blockers and experiencing fatigue, sexual dysfunction, or sleep issues, those symptoms matter. They affect your quality of life. They’re worth discussing, especially if this new research suggests the drug may not be doing what it was supposed to.
The Bigger Picture
This story fits a pattern that should make every man over 40 skeptical of “standard of care” as a concept.
Standard of care often reflects what worked decades ago in a different medical environment. It rarely gets rigorously re-tested. It gets handed down, protocol to protocol, until someone finally runs the numbers — and sometimes the numbers say what they said here.
We’ve seen it with hormone replacement. We’ve seen it with low-fat dietary guidelines. We’ve seen it with a dozen other treatments that were once considered gospel.
The lesson isn’t to distrust medicine wholesale. The lesson is to ask questions. To understand what evidence backs your specific treatment plan. To know that “we’ve always done it this way” is not a medical justification.
REBOOT was conducted with no pharmaceutical industry funding. That matters. Because when nobody’s making money off the answer, you’re more likely to get the truth.
The truth here is that for millions of heart attack survivors with preserved heart function, a drug they were told they needed may not be helping them at all.
That’s worth knowing.
Recommended reading: 7 Supplements Men Over 40 Actually Need | How Diet Powers Gut Health to Beat Obesity and Heart Disease After 40
Want weekly, no-BS health and lifestyle intel built for men over 40? Join the newsletter.
FAQ
What are beta blockers used for? Beta blockers are a class of drugs that slow the heart rate and reduce the force of the heart’s contractions. They’re prescribed for high blood pressure, irregular heart rhythms, chest pain, and for decades have been a standard part of post-heart attack treatment.
What did the REBOOT Trial find? The REBOOT Trial, published in the New England Journal of Medicine, found that beta blockers did not significantly reduce death, repeat heart attack, or hospitalization for heart failure in heart attack patients with preserved heart function. The study followed over 8,500 patients for nearly four years.
Are beta blockers dangerous for women? A companion study found that women who took beta blockers after a heart attack had a higher risk of death, heart attack, or hospitalization for heart failure compared to women who didn’t. This increased risk was not seen in men. Women with fully normal heart function showed a 2.7% higher absolute risk of death over the study period.
Should I stop taking beta blockers? No — not without talking to your doctor first. Stopping beta blockers abruptly can cause dangerous rebound effects. If you’ve had a heart attack and your heart function is preserved, the REBOOT findings give you real grounds to have a serious conversation with your cardiologist about your treatment plan. Don’t make that decision alone.
What does ejection fraction mean? Ejection fraction is a measurement of how much blood the heart pumps out with each beat. A normal ejection fraction is 50% or higher. The REBOOT Trial specifically looked at patients with preserved ejection fraction — meaning their hearts were still pumping normally — and found no benefit from beta blockers in this group.
